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Voiding Dysfunction
Comparison of TOA and TOT for Treating Female Stress Urinary 
Incontinence: Short-Term Outcomes
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Purpose: The transobturator adjustable tape (TOA) sling operation is a new procedure 
that allows for the adjustment of tension after surgical intervention, thus permitting 
correction of postoperative incontinence or obstruction. The aim of this study was to 
compare the efficacy and safety of TOA with that of the transobturator tape (TOT) 
procedure.
Materials and Methods: Between 2008 and 2009, women with stress urinary incon-
tinence (SUI) underwent TOT (n=63) or TOA (n=40). The preoperative evaluation in-
cluded history taking, physical examination, voiding diary, stress and 1-hour pad tests, 
and a comprehensive urodynamic examination. Postoperative evaluation was per-
formed at the 1-week and 3-month postoperative follow-up visits.
Results: The overall cure rate was 90.0% for the TOA group and 85.7% for the TOT group. 
The rate of satisfaction was higher in the TOA group than in the TOT group (95.0% 
vs. 85.6%). Four patients in the TOA group needed reduced tension as the result of uri-
nary obstruction. The tension of the mesh was tightened in 1 patient because of a certain 
degree of continuing incontinence. The residual urine volume was significantly lower 
in the TOA group than in the TOT group (7.8 ml vs. 43 ml, p=0.01).
Conclusions: TOA allowed postoperative readjustment for a number of days after surgi-
cal intervention, which allowed for good short-term treatment outcomes. These data 
suggest that better subjective and objective results and residual urine volume can be 
obtained in the TOA group than those achieved with the traditional non-adjustable 
mesh and without significant postoperative complications.
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INTRODUCTION
Stress urinary incontinence (SUI) is defined as the in-
voluntary leakage of urine on effort, exertion, or coughing 
[1,2]. These symptoms always cause a negative impact on 
quality of life, such as the physical, psychological, and so-
cial well-being of the affected women. Surgery is the most 
effective treatment for SUI.
In 2001, Delorme described an attempt to reduce the 
morbidity of retropubic needle passage, an alternative ap-
proach with a transobturator tape (TOT) [3]. The TOT pro-
cedure has been progressively developing to avoid bladder 
injury, nerve injury, and operation wound complications 
[4]. With the TOT procedure, however, it is difficult to apply 
the correct degree of tension during surgery. Davila et al 
noted that there was less voiding dysfunction after TOT 
than after the tension-free vaginal tape (TVT) procedure 
[5]. But others did not find any significant differences [6,7]. 
When the tape is too loose, incontinence persists. On the 
other hand, when the tape is too tight, urinary obstruction 
occurs. But tension adjustment is difficult with this method. 
Thus, the adjustable sling operation was developed. 
Errando et al noted that the REMEEX system (Mechanical 
External Regulation) allows the readjustment to be per-
formed 24 hours after the operation [8]. In an initial report 
on 21 cases at 12 months of follow-up, Iglesias et al reported Korean J Urol 2010;51:544-549
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a subjective cure rate of 90% [9]. The procedure was safe 
and successful, but serious though rare complications have 
been reported with this technique, including bladder in-
jury and wound infection [9]. Thus, the transobturator ad-
justable tape (TOA) was developed to reduce these com-
plications. The adjustable transobturator tape has been 
shown to allow for adjustment of tension for several days 
after surgical intervention, thus permitting correction of 
postoperative symptoms. Several different midurethral 
sling systems are commercially available, but the new ad-
justable sling operation has not been well studied. In this 
study, we present a retrospective comparison of the results 
and complications associated with the TOA and TOT proce-
dures by one urologist after short-term follow-up.
MATERIALS AND METHODS
We reviewed the files of 103 women referred to our hospital 
for suburethral tape between June 2008 and June 2009. 
Each patient underwent one of two techniques (TOA: A.M.I 
TOA Sling
®, Agency for Medical Innovations GmbH, 
Austria; TOT: Tension Free Obturator Tape
®, Dowmedics, 
Korea) in accordance with the scheduling order. All pa-
tients were given a routine workup for incontinence, in-
cluding history, physical examination, stress cough test, 
standard 1-hour pad test, uroflowmetry, post-void residual 
(PVR) urine measurement, and the complete multi-chan-
nel urodynamic study. All medical charts were retro-
spectively reviewed for certain data, including age, body 
weight, height, urodynamic study, and type of suburethral 
tape. We reviewed complications, postoperative urinary 
symptoms, and outcomes. Our study excluded the presence 
of any urinary tract infection, urgency incontinence, de-
trusor overactivity, intrinsic sphincteric deficiency (ISD), 
impaired detrusor contraction, previous anti-incontinence, 
and pelvic support surgery. We excluded patients who had 
pelvic prolapse greater than stage I on the International 
Continence Society (ICS) grading system. 
During the pelvic examination, the severity of the vagi-
nal wall defect was determined by using the pelvic organ 
prolapse quantification (POP-Q) system [10]. The stress 
cough test was performed with the patient in the standing 
position with 300 ml bladder filling. Urodynamic study was 
performed with the patient in a birthing chair at a 
45-degree angle. After catheterization, cystometry was 
performed by using a Laborie 8 Fr double-lumen urody-
namic catheter at a fill rate of 50 ml per minute. First desire, 
strong desire, and maximal cystometric capacity were 
recorded. The Valsalva leak point pressure (VLPP), a 
measurement of the lowest abdominal pressure required 
to produce urine leakage, was also recorded. The VLPP was 
obtained with the subject seated when the total infused vol-
ume of sterile water reached 300 ml. A VLPP value of less 
than 60 cmH2O was used as the urodynamic criterion for 
the diagnosis of ISD.
Routine postoperative follow-up for all patients included 
office visits at postoperative 7 days and at 3 months. At 
postoperative 7 days, patients underwent a stress cough 
test and uroflowmetry and residual urine volume measu- 
rement. At the 3-month follow-up, a 1-hour pad test was 
added to the previous tests. Objective outcomes were as-
sessed with the cough stress test and 1-hour pad test. SUI 
cure was defined as no leakage of urine during cough stress 
testing and a pad weight gain of less than 2 g on a 1-hour 
pad test during the follow-up visit. Improvement was de-
fined as a more than 50% reduction of urine weight on a 
1-hour pad test and a positive result on the stress cough 
test. Failure was defined as less than a 50% reduction on 
a 1-hour pad test and a positive result on the cough stress 
test. Subjective outcomes were classified as very satisfied, 
satisfied, fair, or dissatisfied. Patients who checked 'very 
satisfied' or 'satisfied' were placed in the satisfaction group. 
Groin and thigh pain was another potential problem after 
transobturator sling operations. Severe pain was defined 
as the presence of pain still requiring analgesic therapy 1 
week after surgery.
TOA is a macroporous, polypropylene, monofilament 
non-elastic type tape. The TOA method is similar to the 
TOT procedure. The TOA tape is situated below the 
mid-urethra via a small incision in the anterior vaginal 
wall. Two strings on either side are situated 1.5 cm from 
the midline of the tape, which is externalized via the ante-
rior vaginal wall. When it is pulled down to reduce tension, 
the TOA group is formed of three strings in each branch of 
the tape situated at the same distance from both thighs. 
These are externalized via the same orifice through which 
the mesh is, when pulled up, to increase the tension. The 
tension is adjusted with minimal tension by placing the 
scissors between the tape and the urethra. The plastic en-
velope is removed, and the redundant portion of the mesh 
is cut. Depending on the distance from the urethra to the 
skin, one or two of the lateral superior strings are also cut. 
Cystoscopy was performed during the procedure. The 
Foley catheter was removed the next day, and the patients 
underwent studies that included measurements of flow 
rate and PVR before being discharged home.
SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL, 
USA) was used for statistical analyses. Comparison of 
baseline patient characteristics as well as baseline uro-
flowmetric parameters was performed by using the in-
dependent t-test and chi-square test. The repeated-meas-
ures ANOVA test was used to compare changes in clinical 
outcomes between the two groups. Statistical significance 
was set at p＜0.05.
RESULTS
A total of 103 participants underwent the TOA procedure 
(n=40) or the TOT procedure (n=63). There were no sig-
nificant differences in preoperative characteristics be-
tween patients in the TOA and TOT groups (Table 1). The 
Mean±SD operating time was 20.4±2.5 minutes in the TOT 
group and 22.5±2.7 minutes in the TOA group. The mean 
hospitalization duration was. 3.0 days in the TOT group Korean J Urol 2010;51:544-549
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TABLE 1. Patient characteristics of the TOT and TOA groups
TOT (n=63) TOA (n=40) p-value
Age   50.9±1.8   53.0±1.3 0.33
Body weight (kg)   63.4±2.3   61.2±1.1 0.34
Height (cm) 153.2±1.3 155.5±0.9 0.92
Menopause (%)     60±10     60±10 0.25
Parity     2.5±0.2     2.5±0.2 0.94
1-hour pad test (g)   19.8±2.9   19.2±2.5 0.89
VLPP   94.9±5.1   86.2±4.6 0.27
Max flow rate (ml/sec)   22.6±1.5     32.1±10.4 0.35
Residual urine (ml)   12.1±4.4   17.0±2.9 0.43
POPQ system 0.54
   Stage 0    48 (76)    30 (75)
   Stage 1    15 (24)    10 (25)
   Stage 2-3               0 (0)     0 (0)
TOT: transobturator tape, TOA: transobturator adjustable tape
VLPP: Valsalva leakage pressure point, POPQ: Pelvic Organ 
Prolapse Quantification system. Data are presented as Mean±
SEM. Numbers in parentheses are percentages.
TABLE 2. Objective and subjective success rates of the TOT and 
TOA groups at postoperative 3 months 
TOT (n=63) TOA (n=40)
Objective result
   Negative cough test 57 (90.5) 38 (95.0)
   Post-op Pad test
     ＜2 g (%) 54 (85.7) 36 (90.0)
     ≥2 g (%)   9 (14.3)   3 (7.5)
Subjective result
   Very satisfied 48 (76.1) 35 (87.5)
   Satisfied   9 (9.5)   3 (7.5)
   Faired   3 (4.8)   1 (2.5)
   Dissatisfied   3 (4.8)   1 (2.5)
TOT: transobturator tape, TOA: transobturator adjustable tape.
Data are presented as frequencies (percentages).
TABLE 3. Changes in uroflowmetric parameters at postoperative
3 months
Preoperative Postoperative
p-value
value value
Max flow rate (ml/sec)
   TOT 22.6±1.5 18.9±1.9 0.92
   TOA   32.1±10.4 30.0±6.2
Residual urine (ml)
   TOT 12.1±4.4   43.0±10.5 0.01
a
   TOA 17.0±2.9   7.8±4.1
Flow time (sec)
   TOT 25.4±6.2 26.2±8.7 0.75
   TOA 24.5±5.4 25.6±7.1
TOT: transobturator tape, TOA: transobturator adjustable tape,
Data are presented as Mean±SEM. 
a: significant (＜0.05), re-
peated-measures ANOVA test
TABLE 4. Comparison of operation-related complications bet- 
ween the TOT and TOA groups
TOT (n=63) TOA (n=40)
Perioperative complications
   Urethral perforation  0 (0)    1 (2.5)
   Vaginal wall injury    3 (4.8) 0 (0)
Early post-operative complications 
 (until 1 week)
   Hematoma  0 (0) 0 (0)
   Thigh or groin pain     4 (6.3) 2 (5)
   UTI 0 (0) 0 (0)
   Obstructive voiding symptom      8 (12.7)      4 (10.0)
Late post-operative complications 
 (3 months)
   Vaginal and urethral erosion  0 (0) 0 (0)
   Obstructive voiding symptom    3 (4.8)    1 (2.5)
TOT: transobturator tape, TOA: transobturator adjustable tape,
UTI: urinary tract infection. Data are presented as frequencies 
(percentages).
and 3.2 days in the TOA group. There was no significant 
difference.
Table 2 shows the objective and subjective outcomes of 
both groups 3 months after surgery. Notably, no statisti-
cally significant differences were found between the two 
types. The overall cure rate was 90% at 3 months in the TOA 
group vs. 85.7% in the TOT group. The satisfaction rate was 
higher in the TOA group than in the TOT group (95.0% vs. 
85.6%). Lee et al noted that the cure rate of the TOT proce-
dure was 92% and the satisfaction rate was 98% [11]. Four 
patients in the TOA group (10%) needed loosening of the 
mesh because of urinary obstruction (flow ＜10 ml/s and/or 
residual urine＞50 ml) after postoperative day 1. In 2 pa-
tients (5.0%) in the TOA group, the tension of the mesh was 
tightened because of a certain degree of continuing incon-
tinence after postoperative day 1. Uroflowmetry tests per-
formed before and after surgery showed that flow in the 
TOT group ranged from 22.6±1.5 ml/s to 18.9±1.9 ml/s, 
whereas that in the TOA group ranged from 32.1±10.4 ml/s 
to 30.0±6.2 ml/s (Table 3). Maximal urine flow decreased 
to an insignificant degree. The change in residual urine vol-
ume was significantly lower in the TOA group than in the 
TOT group (7.8 ml vs. 43 ml, p=0.01, repeated-measures 
ANOVA test). There was no definite difference in voiding 
volume or maximal urine flow between the two groups. 
Postoperative complications are shown in Table 4. 
Vaginal wall injury occurred in 3 patients (4.8%) in the TOT 
group and urethral perforation occurred in 1 patient (2.5%) 
in the TOA group. We promptly repaired the vaginal wall 
injury, and the patient with urethral perforation was 
catheterized for 3 days. There were no cases of wound in-
fection, tape erosion, or urinary tract infection (WBC＞5 in 
urine analysis) in either group. Five patients (12.5%) in the 
TOA group tended to still have continuing groin pain 3 days 
after surgery. The incidence of such pain was 6.3% of the 
TOT group compared with 5% of the TOA group 7 days after Korean J Urol 2010;51:544-549
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FIG. 1. (A) Lidocaine injection on Rt. vaginal wall before loosening of the mesh. (B) Rt. vaginal string was pulled down 1 cm for 
loosening of the mesh due to obstruction. (C) Both superior strings were pulled up 0.5 cm for tightening of the mesh due to stress 
urinary incontinence (SUI).
surgery. The cause of these results may have been that with 
the TOA procedure the strings remained until the end of 
the adjustment period. The patients received analgesic 
agents for 7 days. Three patients in the TOA group had im-
proved pain 1 week after surgery, but two patients (5%) had 
persistent groin pain until 1 week after surgery. Four pa-
tients (6.4%) in the TOT group had thigh pain, and we con-
tinued to order analgesic agents 1 week after surgery. The 
pain was improved at 2 weeks after surgery in all patients. 
Postoperative urinary obstruction was seen in 8 patients 
(12.8%) in the TOT group. Three patients (4.8%) in the TOT 
group had persistent obstructive voiding symptoms (flow 
rate＜10 ml/s and/or residual urine＞50 ml) at the 3-month 
follow-up visit. These patients still showed no improve-
ment, so we performed urethrolysis at 3-5 months after 
surgery. One patient (2.5%) in the TOA group had a compli-
cation of urethral obstruction at 3 months after surgery; 
this case required urethrolysis at 5 months after surgery.
DISCUSSION
We retrospectively reviewed the data for 103 women re-
ferred to our hospital for suburethral tape operation only. 
The mean age, parity, height, body weight, preoperative 
clinical parameters, and preoperative urodynamic param-
eters were similar in both groups. The patients did not have 
pelvic organ prolapse (POP: stage≥2), ISD, bladder outlet 
obstruction, or impaired detrusor muscle contraction. The 
cure rate of the TOT procedure varies from 51% to 97%, de-
pending on the definition used for success, the outcome in-
struments, and discrepancies in the studied populations 
[5,12-15]. Maroto et al noted in their results of the TOA pro-
cedure that 90% of the patients were objectively stress con-
tinent [12], 6.5% of the patients had considerable improve-
ment, and 3.5% of the patients experienced failure during 
the mean follow-up period of 24.7 months. In the present 
study, the cure rate associated with the TOA procedure was 
90% and was comparable to the 85.7% cure rate associated 
with the TOT procedure. The high cure rate of the TOA pro-
cedure resulted from the adjustable system after the imme-
diate postoperative period. We noted a higher satisfaction 
rate for the TOA group (TOT: 85.6%; TOA: 95%). 
The two most frequent problems after stress incon-
tinence surgery are persistence of incontinence and void-
ing dysfunction, both of which are related to how loose or 
how tight the tape is implanted [16]. Despite all the im-
provements achieved with synthetic slings, Stanton et al 
said as follows: “Thus the ideal sling should be of consistent 
strength, readily available, adjustable and removable 
[17].” Readjustment was easily performed under local 
anesthesia. For the TOA sling operation, loosening of the 
mesh resulted in a significant increase in flow and elimi-
nation of residual urine. Tightening of the mesh resulted 
in continence. Although most urinary retention resolves 
with conservative treatment including medication, ure-
thral dilation, or intermittent catheterization, refractory 
urethral obstruction ultimately requires midline or lateral 
excision of the tape [18]. Davila et al found de novo voiding 
symptoms after the TOT procedure in 6.7% of their oper-
ation cases, and in 7%, the preoperative voiding symptoms 
worsened [5]. Tape cutting or tape adjustment were neces-
sary in up to 5% after the TOT procedure [13]. In the present 
study, eight patients (12.7%) in the TOT group had under-
gone urethral pull-down after postoperative 1 day. In ure-
thral pull-down, a Hegar dilator is inserted in the urethra 
and pulled down with the aim of moving downward and 
loosening the tape in the TOT group. If the maximum flow 
rate is less than 10 ml/s or there is more than 50 ml of re-
sidual urine after the TOA procedure, tension is released 
from the mesh by pulling down on one side only of the vagi-
nal strings, approximately 1 cm [14]. We performed the 
same method after postoperative 1 day (Fig. 1). The pa-
tients were checked again by uroflowmetry and residual 
urine volume after 3 hours. If the patients showed SUI in 
the cough stress test, then we immediately pulled up the 
strings on each side, approximately 0.5 cm (Fig. 1). Conti- Korean J Urol 2010;51:544-549
548 Youn et al
nence was tested, and the procedure was repeated until the 
patient was continent with a maximum flow rate equal to 
or greater than 10 ml/s and when there was less than 50 
ml of residual urine. The strings were cut and extracted, 
and the patient was discharged. We rechecked the results 
of the cough test and uroflowmetry and residual urine at 
postoperative 1 week and 3 months. In another study, the 
tension was adjusted in 44% of patients: in 34%, the tension 
was increased, and in 10%, the tension was decreased [14]. 
In the present study, 10% of the patients in the TOA group 
needed a decrease in the tension and 5% of the patients 
needed an increase in the tension due to a certain degree 
of continuing incontinence. After tightening or loosening 
of the mesh, the patients had higher satisfaction and con-
tinence and a higher flow rate. 
A randomized study from Finland revealed that 16% of 
the TOT patients had groin pain compared with 1.5% of the 
TVT patients, which led to an increased need for analgesia 
in the transobturator group [19]. 
Three cases of vaginal wall injury in the TOT group were 
encountered, indicating that the needle passed through 
the dissection space between the vagina and the urethra. 
We performed surgical implantation of the tape with a view 
of avoiding urethral injury, so the needle passed close to the 
vaginal surface. Urethral injuries are believed to occur be-
cause of poor surgical technique, which damages the in-
tegrity of the urethral tissue or its blood supply; because 
of excessive tension placed on the tape; or as the result of 
local infection [20]. The transobturator sling procedure has 
been shown to have a lower incidence of bladder injury 
(0.5%), urethral injury (0.5%), and lower urinary tract in-
juries (1%) than does the TVT procedure [20]. We think the 
recommendation for cystoscopy after passage of the trocars 
cannot be overemphasized, even if the rate of urethral in-
jury was very low, because these complications can be 
treated promptly in the operation field.
We conclude that TOA is an effective and simple proce-
dure because the procedure had minimal complications 
and a high success rate. Our results show that the persis-
tence of stress incontinence and the development of ob-
struction after surgery depend largely on the tension ap-
plied to the mesh, looser or tighter, during the procedure. 
TOA allows for postoperative adjustment of tension, thus 
permitting correction of postoperative incontinence or 
obstruction. The present study was limited in that the re-
sults were recorded until only 3 months after surgery. 
Hence, the study may not properly indicate long-term pro-
spective outcomes. Clearly, further follow-up is required, 
and more comparative studies are warranted to evaluate 
the outcome and safety of these novel procedures for the 
treatment of SUI.
CONCLUSIONS
The TOA procedure allowed postoperative readjustment of 
the suburethral sling pressure for a number of days after 
surgical intervention, which resulted in good short-term 
results. These data suggest that better objective and sub-
jective results and residual urine volume can be obtained 
with the TOA procedure than are achieved with the tradi-
tional non-adjustable mesh and without significant post-
operative complications. However, these data had a short 
postoperative follow-up period and excluded women with 
SUI with co-morbid status. Long-term follow-up will be re-
quired to fully evaluate the results and safety associated 
with these procedures. 
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